ATE494375T1 - Frazzled nukleotidsequenzen, expressions- produkte, zusammensetzungen und verwendungen - Google Patents

Frazzled nukleotidsequenzen, expressions- produkte, zusammensetzungen und verwendungen

Info

Publication number
ATE494375T1
ATE494375T1 AT05008181T AT05008181T ATE494375T1 AT E494375 T1 ATE494375 T1 AT E494375T1 AT 05008181 T AT05008181 T AT 05008181T AT 05008181 T AT05008181 T AT 05008181T AT E494375 T1 ATE494375 T1 AT E494375T1
Authority
AT
Austria
Prior art keywords
nucleotide sequences
compositions
expression products
frazzled
frazzled nucleotide
Prior art date
Application number
AT05008181T
Other languages
English (en)
Inventor
Hazel Sive
Benjamin Sun
Lisa A Racie
Edward R Lavallie
Janet E Paulsen
Original Assignee
Genetics Inst Llc
Whitehead Biomedical Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst Llc, Whitehead Biomedical Inst filed Critical Genetics Inst Llc
Application granted granted Critical
Publication of ATE494375T1 publication Critical patent/ATE494375T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05008181T 1997-07-11 1998-04-28 Frazzled nukleotidsequenzen, expressions- produkte, zusammensetzungen und verwendungen ATE494375T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/893,654 US6165748A (en) 1997-07-11 1997-07-11 Frazzled nucleotide sequences and expression products

Publications (1)

Publication Number Publication Date
ATE494375T1 true ATE494375T1 (de) 2011-01-15

Family

ID=25401869

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05008181T ATE494375T1 (de) 1997-07-11 1998-04-28 Frazzled nukleotidsequenzen, expressions- produkte, zusammensetzungen und verwendungen
AT98920893T ATE313627T1 (de) 1997-07-11 1998-04-28 Frazzled nukleotidsequenzen, expressionsprodukte, zusammensetzungen und verwendungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98920893T ATE313627T1 (de) 1997-07-11 1998-04-28 Frazzled nukleotidsequenzen, expressionsprodukte, zusammensetzungen und verwendungen

Country Status (8)

Country Link
US (1) US6165748A (de)
EP (2) EP1000143B1 (de)
JP (2) JP2001509382A (de)
AT (2) ATE494375T1 (de)
AU (1) AU751803B2 (de)
DE (2) DE69842091D1 (de)
MX (1) MXPA00001427A (de)
WO (1) WO1999002679A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673909B1 (en) * 1998-08-25 2004-01-06 The General Hospital Corporation Oligonucleotides for dysferlin, a gene mutated in distal myopathy and limb girdle muscular dystrophy
EP1266664A1 (de) * 2000-03-10 2002-12-18 Chugai Seiyaku Kabushiki Kaisha Preparationen für chondrogenesis
US20030044409A1 (en) * 2001-05-01 2003-03-06 Carson Dennis A. Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
US7713526B2 (en) 2001-05-01 2010-05-11 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
US7682607B2 (en) * 2001-05-01 2010-03-23 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
EP1639097B1 (de) 2003-06-25 2013-08-07 Ottawa Health Research Institute Methoden und zusammensetzungen um stammzellwachstum und -differenzierung zu modulieren
EP1991246B1 (de) 2006-02-22 2013-09-11 Zhenglun Zhu Behandlung von entwicklungsbedingten störungen
WO2007124448A2 (en) * 2006-04-20 2007-11-01 Rosero Spencer Z Method and apparatus for the management of diabetes

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419446A (en) 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
EP0105014B1 (de) 1982-09-24 1992-05-20 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Wiederherstellung von Gewebe bei Tieren
US4588684A (en) 1983-04-26 1986-05-13 Chiron Corporation a-Factor and its processing signals
DK518384A (da) 1984-01-31 1985-07-01 Idaho Res Found Vektor til fremstilling af et gen-produkt i insektceller, fremgangsmaade til dens fremstilling samt dens anvendelse
NZ212645A (en) 1984-07-06 1990-02-26 Sandoz Ltd Method for producing primate granulocyte-macrophage colony stimulating factor (gm-csf)
DE3586386T2 (de) 1984-10-05 1993-01-14 Genentech Inc Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung.
US5646016A (en) 1991-02-06 1997-07-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
ATE215605T1 (de) 1991-06-24 2002-04-15 Pacific Biomedical Res Inc In langzeitkultur gehaltene hormon-absondernde pankreatische zellen
US6133232A (en) * 1996-06-20 2000-10-17 The Regents Of The University Of California Endoderm, cardiac and neural inducing factors
AU4981797A (en) * 1996-10-11 1998-05-11 Government Of The United States Of America, The Isolation and method of using tissue growth-inducing frzb protein

Also Published As

Publication number Publication date
EP1591526A3 (de) 2007-08-08
AU7363198A (en) 1999-02-08
MXPA00001427A (es) 2005-01-25
JP2009142287A (ja) 2009-07-02
AU751803B2 (en) 2002-08-29
EP1000143B1 (de) 2005-12-21
EP1591526B1 (de) 2011-01-05
DE69832880T2 (de) 2006-06-22
DE69832880D1 (de) 2006-01-26
EP1591526A2 (de) 2005-11-02
DE69842091D1 (de) 2011-02-17
JP2001509382A (ja) 2001-07-24
WO1999002679A1 (en) 1999-01-21
EP1000143A1 (de) 2000-05-17
US6165748A (en) 2000-12-26
ATE313627T1 (de) 2006-01-15

Similar Documents

Publication Publication Date Title
IL149459A0 (en) Recombinant gelatins
EP0667392A3 (de) Bleichmittelzusammensetzungen.
DE69708120D1 (de) Laser-absorbierende, lichtbleichbare zusammensetzungen
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
DK0996430T3 (da) Nukleotidanalogsammensætninger
TR199800375A3 (tr) Selant kompozisyonlari.
ATE490311T1 (de) Mutanten der alpha-amylase
ID23374A (id) Halogenopirimidin
BR9813569B1 (pt) processo, e, composiÇço de aditivo alimentÍcio.
IL125124A0 (en) Dimeric forms of the protein fapalpha and uses thereof
ZA981017B (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines.
TR199501650A2 (tr) Agiz bilesimleri.
DE60120712D1 (en) Kallikrein gen
TR199501645A2 (tr) Agiz bilesimleri.
ATE313627T1 (de) Frazzled nukleotidsequenzen, expressionsprodukte, zusammensetzungen und verwendungen
ATE305517T1 (de) Neurotrypsin
BR0012043B1 (pt) composiÇço de tratamento de cabelo.
BR9916537B1 (pt) composição de fragráncia, e, produto.
IT242987Y1 (it) Guarnitura per mobili.
DE69811651D1 (de) Enthaarungszusammensetzungen, die bereitung und die verwendung derselben
TR199902434T2 (xx) Bakteriyel plazmidler.
TR199501649A2 (tr) Agiz bilesimleri.
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
ATE251619T1 (de) 1,4-dioxacycloalkan-2-one und 1,4-dioxacycloalken-2-one
TR199501651A2 (tr) Agiz bilesimleri.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties